oncgnostics GmbH closed a funding round (amount undisclosed) in Sep 2023. The company is based in Germany. Investors in the round: Grande Bio-tech Co.. Data as of 7 Aug 2026.
Amount undisclosed or unconverted.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
